Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Understanding Privacy Coins: Zcash, Monero and the Future of Anonymity January 15, 2026 CoTec to Host Investor Update January 14, 2026 Heliostar Provides 2026 Guidance and Growth Plan January 13, 2026